LivingGLP1
Study S002541

Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome

ClinicalTrials.gov record

Registration

Registration
NCT07773272
Acronym
SLIM-3
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
1215
Start
2026-03-16
Primary completion
2029-03-31
Lead sponsor
Zuyderland Medisch Centrum
Conditions
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI); Hypercholerolemia; Hypertension; Diabete Mellitus; Cardiovascular Risk Management
Interventions
DRUG:Rapid ESC-guideline based secondary prevention following myocardial infaction
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • MACCE within 2 years after the ACS and PCI [From enrollment to end of 2 year follow-up]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.